A new publication dated September 8, 2026 addresses etelcalcetide, an approved compound. The paper, titled "Racial and Ethnic Variations in Reductions in Etelcalcetide Use After Withdrawal of the Transitional Drug Add-on Payment Adjustment," appears in the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation.
The publication is indexed under PubMed ID 42710611. It examines patterns of etelcalcetide use following the end of a transitional drug add-on payment adjustment, with a focus on racial and ethnic variations in these changes.
No findings, outcomes, or conclusions from the study are included here beyond the title and publication details provided. Readers interested in the full results should consult the journal article directly for the complete analysis and data.
This brief reports only the existence and bibliographic details of this new publication as recorded in the source event. For additional background on this compound, readers can refer to the compound overview.